Log In
Print
BCIQ
Print
Print this Print this
 

Travoprost-loaded punctum plug (OTX-TP2)

  Manage Alerts
Collapse Summary General Information
Company Ocular Therapeutix Inc.
DescriptionHydrogel-based punctum plug that delivers sustained-release travoprost over 2 months
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationGlaucoma
Indication DetailsTreat glaucoma
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today